Despite only being available in dispensaries, the beer was conveniently portable, which is something you can't say about all currently available cannabis products.
And if you don't finish a can, you can re-close the tab at the top.
The Lagunitas brew is currently available in two varieties. One is purely THC, with 10mg per can (roughly the same as you'd find in an edible like a gummy); the other is a hybrid variety with 5mg of THC and 5mg of CBD.
The hybrid version is designed to have more subdued and relaxing effects.
Heineken's move into "beer" made with CBD and THC instead of alcohol is strategic.
Consumer demand for marijuana products is growing fast as state-based legalization campaigns spread and as scientific awareness about the drug increases.
There has long been mainstream awareness of THC, marijuana's main psychoactive compound.
Now there's also an emerging interest in CBD, the compound thought to be responsible for many of the drug's therapeutic effects — such as pain relief.
Besides beer-like drinks, a range of CBD products made from hemp are popping up in stores around the country.
Lotions, balms, beverages, vape pens, and dog treats are just a few of the products making a splash on the retail scene.
Putting a cannabis product in a beverage is a smart move for another reason, too: it could help save the struggling beer and soda industry.
Expected to reach roughly $75 million in sales by 2030, cannabis is already set to eclipse soda, according to research firm Cowen & Co.
In recent years, many major beer labels — including Heineken — have been plagued by what analysts say is a lack of interest among millennials.